AI assistant
Sending…
Immix Biopharma, Inc. — Director's Dealing 2021
Dec 20, 2021
34423_dirs_2021-12-20_eef3a2a0-feb4-452b-bcf1-f59b3bc12a7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immix Biopharma, Inc. (IMMX)
CIK: 0001873835
Period of Report: 2021-12-20
Reporting Person: Rachman Ilya M (Director, CEO and Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-20 | Common Stock | P | 2500 | $5.00 | Acquired | 902500 | Direct |
More from Immix Biopharma, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 21
Share Issue/Capital Change
2026
May 21
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 7
Proxy Solicitation & Information Statement
2026
Apr 6
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 25